Pembrolizumab in men with heavily treated metastatic castrate‐resistant prostate cancer

MLA

Matthew D. Tucker, et al. “Pembrolizumab in Men with Heavily Treated Metastatic Castrate‐resistant Prostate Cancer.” Cancer Medicine, vol. 8, no. 10, Aug. 2019, pp. 4644–55. EBSCOhost, https://doi.org/10.1002/cam4.2375.

APA

Matthew D. Tucker, Jason Zhu, Daniele Marin, Rajan T. Gupta, Santosh Gupta, William R. Berry, Sundhar Ramalingam, Tian Zhang, Michael Harrison, Yuan Wu, Patrick Healy, Stacey Lisi, Daniel J. George, & Andrew J. Armstrong. (2019). Pembrolizumab in men with heavily treated metastatic castrate‐resistant prostate cancer. Cancer Medicine, 8(10), 4644–4655. https://doi.org/10.1002/cam4.2375

Chicago

Matthew D. Tucker, Jason Zhu, Daniele Marin, Rajan T. Gupta, Santosh Gupta, William R. Berry, Sundhar Ramalingam, et al. 2019. “Pembrolizumab in Men with Heavily Treated Metastatic Castrate‐resistant Prostate Cancer.” Cancer Medicine 8 (10): 4644–55. doi:10.1002/cam4.2375.